eSignal IPO Calendar

Week of Expected Pricing	Withdrawn
Company Name	TOBIRA THERAPEUTICS, INC.
Proposed Ticker	N/A
CUSIP	N/A
Business Description	A clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics to treat liver disease, human immunodeficiency virus, or HIV, fibrosis and inflammation.
Lead Underwriter	Leerink Partners LLC
Co-Managers	Needham & Company, LLC,Oppenheimer & Co. Inc.
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A